Bactrim and Tazidime drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Bactrim (sulfamethoxazole; trimethoprim) and Tazidime (ceftazidime). Common drug interactions include neutropenia among females and pyrexia among males.
The phase IV clinical study analyzes what interactions people have when they take Bactrim and Tazidime. It is created by eHealthMe based on reports of 502 people who take the same drugs from the FDA, and is updated regularly.
What is Bactrim?
Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.
What is Tazidime?
Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
502 people who take Bactrim and Tazidime together, and have interactions are studied.
What are the common drug interactions of Bactrim and Tazidime, by gender? *
What are the common drug interactions of Bactrim and Tazidime, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Bactrim and Tazidime?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Bactrim and Tazidime:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bactrim:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tazidime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bactrim and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tazidime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and ceftazidime (the active ingredients of Bactrim and Tazidime, respectively), and Bactrim and Tazidime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypoglycemia and drugs of ingredients of nintedanib esylate - now
- Alcohol Poisoning and drugs of ingredients of rivaroxaban - a second ago
- Could Losartan Potassium cause Skin Discoloration - Bluish? - a second ago
- General Physical Health Deterioration and drugs of ingredients of dolutegravir sodium; lamivudine - 2 seconds ago
- Could Diphenhydramine Hydrochloride cause Eye Pain? - 5 seconds ago
- Heart Rate Irregular and drugs of ingredients of prednisolone acetate - 5 seconds ago
- Urinary Tract Inflammation and drugs of ingredients of aspirin - 9 seconds ago
- Heart Rate Decreased and drugs of ingredients of betamethasone dipropionate - 10 seconds ago
- Nyquil and Tylenol drug interactions for men aged 50-59 - 11 seconds ago
- Ocular Discomfort and drugs of ingredients of lidocaine - 13 seconds ago